Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Illumina
Pharma
Takeda, Sun, Ono—Fierce Pharma Asia
Takeda sharpens its oncology focus. Sun Pharma buys PD-L1 developer Checkpoint Therapeutics. Ono obtained an ASO from Ionis. Plus more.
Angus Liu
Mar 14, 2025 8:45am
Trump policy, Pfizer, CMIC—Fierce Pharma Asia
Mar 7, 2025 8:05am
Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia
Feb 14, 2025 9:51am
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Feb 7, 2025 9:00am
Illumina recruits Pfizer alum as new commercial chief
Jun 3, 2024 1:37pm
'The Top Line': Digital phenotyping, plus this week's headlines
Jul 14, 2023 6:00am
